These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 26244788)
1. Costs of venous thromboembolism associated with hospitalization for medical illness. Cohoon KP; Leibson CL; Ransom JE; Ashrani AA; Petterson TM; Long KH; Bailey KR; Heit JA Am J Manag Care; 2015 Apr; 21(4):e255-63. PubMed ID: 26244788 [TBL] [Abstract][Full Text] [Related]
2. Direct Medical Costs Attributable to Cancer-Associated Venous Thromboembolism: A Population-Based Longitudinal Study. Cohoon KP; Ransom JE; Leibson CL; Ashrani AA; Petterson TM; Long KH; Bailey KR; Heit JA Am J Med; 2016 Sep; 129(9):1000.e15-25. PubMed ID: 27012853 [TBL] [Abstract][Full Text] [Related]
3. Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study. Cohoon KP; Leibson CL; Ransom JE; Ashrani AA; Park MS; Petterson TM; Long KH; Bailey KR; Heit JA Surgery; 2015 Mar; 157(3):423-31. PubMed ID: 25633736 [TBL] [Abstract][Full Text] [Related]
4. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries. Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169 [TBL] [Abstract][Full Text] [Related]
5. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective. Lin J; Lingohr-Smith M; Kwong WJ J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for venous thromboembolism in nursing home residents. Liebson CL; Petterson TM; Bailey KR; Melton LJ; Heit JA Mayo Clin Proc; 2008 Feb; 83(2):151-7. PubMed ID: 18241624 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study. Park MS; Perkins SE; Spears GM; Ashrani AA; Leibson CL; Boos CM; Harmsen WS; Jenkins DH; Bailey KR; Ballman KV; Heit JA Thromb Res; 2016 Aug; 144():40-5. PubMed ID: 27284980 [TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in nursing home residents: role of selected risk factors. Leibson CL; Petterson TM; Smith CY; Bailey KR; Ashrani AA; Heit JA J Am Geriatr Soc; 2012 Sep; 60(9):1718-23. PubMed ID: 22880626 [TBL] [Abstract][Full Text] [Related]
9. Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States. Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M J Manag Care Spec Pharm; 2015 Oct; 21(10):965-72. PubMed ID: 26402395 [TBL] [Abstract][Full Text] [Related]
10. Identifying in-hospital venous thromboembolism (VTE): a comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort. Leibson CL; Needleman J; Buerhaus P; Heit JA; Melton LJ; Naessens JM; Bailey KR; Petterson TM; Ransom JE; Harris MR Med Care; 2008 Feb; 46(2):127-32. PubMed ID: 18219240 [TBL] [Abstract][Full Text] [Related]
11. Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study. Ashrani AA; Barsoum MK; Crusan DJ; Petterson TM; Bailey KR; Heit JA Thromb Res; 2015 Jun; 135(6):1110-6. PubMed ID: 25891841 [TBL] [Abstract][Full Text] [Related]
12. Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US. Amin A; Deitelzweig S; Bucior I; Lin J; Lingohr-Smith M; Menges B; Neuman WR J Med Econ; 2019 Nov; 22(11):1119-1125. PubMed ID: 31084383 [No Abstract] [Full Text] [Related]
13. Venous Thromboembolism (VTE) Incidence and VTE-Associated Survival among Olmsted County Residents of Local Nursing Homes. Petterson TM; Smith CY; Emerson JA; Bailey KR; Ashrani AA; Heit JA; Leibson CL Thromb Haemost; 2018 Jul; 118(7):1316-1328. PubMed ID: 29966167 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study. Ashrani AA; Gullerud RE; Petterson TM; Marks RS; Bailey KR; Heit JA Thromb Res; 2016 Mar; 139():29-37. PubMed ID: 26916293 [TBL] [Abstract][Full Text] [Related]
15. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. Grosse SD; Nelson RE; Nyarko KA; Richardson LC; Raskob GE Thromb Res; 2016 Jan; 137():3-10. PubMed ID: 26654719 [TBL] [Abstract][Full Text] [Related]
16. All-cause and disease-related health care costs associated with recurrent venous thromboembolism. Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Hossou Y; Schein J; Kaatz S Thromb Haemost; 2013 Dec; 110(6):1288-97. PubMed ID: 24085327 [TBL] [Abstract][Full Text] [Related]
17. Rethinking guidelines for VTE risk among nursing home residents: a population-based study merging medical record detail with standardized nursing home assessments. Leibson CL; Petterson TM; Smith CY; Bailey KR; Emerson JA; Ashrani AA; Takahashi PY; Heit JA Chest; 2014 Aug; 146(2):412-421. PubMed ID: 24626961 [TBL] [Abstract][Full Text] [Related]
18. Direct medical costs of polymyalgia rheumatica. Kremers HM; Reinalda MS; Crowson CS; Zinsmeister AR; Hunder GG; Gabriel SE Arthritis Rheum; 2005 Aug; 53(4):578-84. PubMed ID: 16082650 [TBL] [Abstract][Full Text] [Related]
19. Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US. Heit JA; Crusan DJ; Ashrani AA; Petterson TM; Bailey KR Blood; 2017 Jul; 130(2):109-114. PubMed ID: 28483763 [TBL] [Abstract][Full Text] [Related]